E-Cadherin Gene Promoter Hypermethylation in Primary Human Gastric Carcinomas

Authors:
  • JYJing Yin
    Jing Yin
  • SWSuna Wang
    Suna Wang
  • AFA. Steven Fleisher
    A. Steven Fleisher
  • TZTongtong Zou
    Tongtong Zou
  • JAJohn M. Abraham
    John M. Abraham
  • DKDehe Kong
    Dehe Kong
  • KSKara N. Smolinski
    Kara N. Smolinski
  • SJStephen P. James
    Stephen P. James
  • SSSteven G. Silverberg
    Steven G. Silverberg
  • SNSatoshi Nishizuka
    Satoshi Nishizuka
Open Access
Publisher website
Google Scholar
Abstract
Background: E (epithelial)-cadherin, the cell adhesion molecule also considered a potential invasion/metastasis suppressor, is mutationally inactivated in nearly half of all undifferentiated-scattered (diffuse-type) gastric carcinomas. In addition, silencing of E-cadherin by CpG methylation within its promoter region has been reported in several gastric carcinoma cell lines. We investigated the methylation status of the E-cadherin promoter region in 53 primary human gastric carcinomas. Methods: Hypermethylation of the E-cadherin promoter was determined by utilizing methylation-specific polymerase chain reaction (PCR)–single-strand conformation polymorphism (MSP–SSCP) analysis followed by direct sequencing of PCR products. Expression of E-cadherin was studied by western blot analysis. All statistical tests were two-sided. Results: Hypermethylation of the E-cadherin promoter was evident in 27 (51%) of 53 primary gastric carcinomas examined by MSP–SSCP. It occurred more frequently in carcinomas of the undifferentiated-scattered type (in 15 [83%] of 18) than in other histologic subtypes (in 12 [34%] of 35) (P = .0011, Fisher's exact test), and it was present at similar rates in early (in six [60%] of 10) versus advanced (in 21 [49%] of 43) carcinomas (P = .73, Fisher's exact test). Methylation occurring at all cytosine–guanosine sequences (CpGs) near the transcriptional start site was confirmed in six of six tumors examined by bisulfite–DNA sequencing, including two early gastric carcinomas. In addition, loss or diminished expression of E-cadherin was confirmed by western blotting in four of the six tumor tissues demonstrating hypermethylation. Conclusions: The E-cadherin promoter frequently undergoes hypermethylation in human gastric cancers, particularly those of the undifferentiated-scattered histologic subtype. E-cadherin promoter hypermethylation is associated with decreased expression and may occur early in gastric carcinogenesis.

This publication has 17 references indexed in Scilit: